Sources
Loading...
Additional media
Loading...
DeepNewz, mobile.
People-sourced. AI-powered. Unbiased News.
Hims & Hers Health Inc. ($HIMS) experienced a notable decline, falling by 9% on March 19, 2025, and has seen a dramatic drop in market capitalization from $15 billion to $7 billion over the past month, representing a 54% decrease. Analysts are observing the stock closely, with one predicting potential near-term price fluctuations, suggesting a downside target of $30 and an upside target of $40, while the stock currently trades at $33. In contrast, another company, Dave, which went public via SPAC in 2022 at a valuation of $4 billion, saw its market cap plummet to $50 million in June 2023. However, it has since rebounded to $1.1 billion, prompting discussions about its potential turnaround in the market.
Unfortunately my line of work doesn’t let me trade the tech names. But outside of tech it is game on… Opening a position here in $HIMS. It sometimes trades like a meme stock but the underlying business is very real. Feels way undervalued. NFA https://t.co/zPQ1eNKp2O
Dave is an insane story. The company SPAC’d in 2022 at a price of $4BN. In June 2023: Dave hit an all time low of $50M market cap. Today they have rebounded to $1.1BN. Is this the turnaround on Wall St no one is discussing enough? What do I have to ask their CEO on 20VC https://t.co/1IzwwTdbGt
$HIMS Near term downside $30. Near term upside $40. Currently $33. I'll take a 2:1 r/r here. Stars aligned for a reprieve bounce. I mean PLTR had theirs, why not HIMS? https://t.co/Z4PH7NaC65
